News

A separate efficacy supplement that included data from patients with cutaneous T-cell lymphoma (CTCL) whose malignant cells did not test positive for the CD25 component of the IL-2

This double-blind, placebo-controlled Phase I study (Study 290-001), is expected to enroll up to 60 adult healthy volunteers. MGCD290 will be administered orally at an initial starting dose

Lorus has also announced that Central America has been added to the territories covered in the exclusive licensing agreement with Zor Pharmaceuticals. Due to the extension of the

Palifosfamide, the active moiety of ifosfamide (IFOS), is a bi-functional alkylator that causes irreparable inter-strand DNA cross-linking, resulting in cell death. Palifosfamide is equal to or more active

The SEEplate cervical plate system incorporates features that are aimed at allowing surgeons an alternative to confirming the secure placement of the anti-back-out mechanism of screws used as

As a result of the acquisition, GlaxoSmithKline (GSK) will become the leading pharmaceutical company in Egypt with a market share of approximately 9%. GSK will acquire 20 branded

Following the recommendation for regulatory approval under the European decentralized procedure, Toctino received national regulatory approval in Finland. Following the regulatory approval of Toctino in Finland, Basilea will

In addition to their appointments to the board, Mr Benjamin has been appointed to serve on the company’s audit committee, and Mr Meyer has been appointed to serve

Amadeus is being developed as a four-armed robotic surgical system that combines aerospace, medical and defense technologies. The Phase B prototype includes improvements in vision system, force feedback,